US Stock MarketDetailed Quotes

XFOWW X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B

Watchlist
  • 0.012
  • 0.0000.00%
15min DelayTrading Jul 31 16:00 ET
0Market Cap0.00P/E (TTM)

X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
27.25%37.29M
22.08%107.52M
-1.48%25.2M
35.03%27.21M
25.45%25.81M
34.56%29.3M
16.89%88.08M
32.54%25.58M
5.41%20.15M
8.28%20.57M
Selling and administrative expenses
140.78%17.44M
31.40%35.51M
51.26%9.93M
34.56%8.13M
51.19%10.2M
-5.52%7.24M
9.38%27.02M
-8.02%6.56M
1.91%6.04M
16.28%6.75M
Research and development costs
-10.01%19.85M
17.95%72.02M
-19.68%15.27M
35.23%19.08M
12.88%15.6M
56.33%22.06M
20.56%61.06M
56.34%19.01M
6.99%14.11M
4.76%13.82M
Operating profit
-27.25%-37.29M
-22.08%-107.52M
1.48%-25.2M
-35.03%-27.21M
-25.45%-25.81M
-34.56%-29.3M
-16.89%-88.08M
-32.54%-25.58M
-5.41%-20.15M
-8.28%-20.57M
Net non-operating interest income expense
-194.89%-808K
68.34%-1.2M
53.38%-441K
75.50%-246K
74.40%-234K
69.89%-274K
-3.91%-3.77M
-2.60%-946K
-9.37%-1M
-1.33%-914K
Non-operating interest income
27.66%1.07M
1,992.24%4.58M
629.80%1.45M
9,814.29%1.39M
22,750.00%914K
27,733.33%835K
2,090.00%219K
6,500.00%198K
600.00%14K
33.33%4K
Non-operating interest expense
68.98%1.87M
44.68%5.78M
64.86%1.89M
60.51%1.63M
25.05%1.15M
21.47%1.11M
9.64%3.99M
23.68%1.14M
10.65%1.02M
1.44%918K
Other net income (expense)
-345.42%-13.65M
483.90%7.63M
354.89%6.54M
5,809.98%25.18M
-10,845.65%-29.66M
646.58%5.56M
79.51%-1.99M
74.29%-2.57M
-224.26%-441K
3.37%276K
Gain on sale of security
-352.90%-13.76M
315.87%7.07M
432.02%6.33M
--25.16M
-9,013.43%-29.86M
2,990.34%5.44M
564.75%1.7M
460.61%1.19M
----
487.72%335K
Special income (charges)
----
--0
--0
--0
--0
----
105.22%509K
--0
--0
--0
-Less:Impairment of capital assets
----
--0
----
----
----
----
--0
----
----
----
-Gain on sale of property,plant,equipment
----
--0
--0
--0
--0
----
--509K
--0
--0
--0
Other non- operating income (expenses)
-14.63%105K
113.20%554K
105.64%212K
103.85%17K
442.37%202K
105.00%123K
-1,085.21%-4.2M
-3,747.57%-3.76M
-495.95%-441K
-128.10%-59K
Income before tax
-115.47%-51.75M
-7.73%-101.09M
34.35%-19.1M
89.45%-2.28M
-162.62%-55.7M
-9.45%-24.02M
-5.82%-93.84M
3.69%-29.09M
-7.07%-21.6M
-8.03%-21.21M
Income tax
375.00%19K
178.57%78K
135.71%33K
300.00%26K
275.00%15K
-82.61%4K
64.71%28K
366.67%14K
-750.00%-13K
-33.33%4K
Net income
-115.51%-51.77M
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
-6.99%-21.59M
-8.02%-21.21M
Net income continuous Operations
-115.51%-51.77M
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
-6.99%-21.59M
-8.02%-21.21M
Minority interest income
Net income attributable to the parent company
-115.51%-51.77M
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
-6.99%-21.59M
-8.02%-21.21M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
-81.74%2.55M
0
287K
0
Net income attributable to common stockholders
-115.51%-51.77M
-4.93%-101.17M
34.27%-19.13M
89.46%-2.31M
-162.64%-55.71M
0.84%-24.02M
6.07%-96.41M
18.96%-29.1M
-8.42%-21.87M
-8.02%-21.21M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 27.25%37.29M22.08%107.52M-1.48%25.2M35.03%27.21M25.45%25.81M34.56%29.3M16.89%88.08M32.54%25.58M5.41%20.15M8.28%20.57M
Selling and administrative expenses 140.78%17.44M31.40%35.51M51.26%9.93M34.56%8.13M51.19%10.2M-5.52%7.24M9.38%27.02M-8.02%6.56M1.91%6.04M16.28%6.75M
Research and development costs -10.01%19.85M17.95%72.02M-19.68%15.27M35.23%19.08M12.88%15.6M56.33%22.06M20.56%61.06M56.34%19.01M6.99%14.11M4.76%13.82M
Operating profit -27.25%-37.29M-22.08%-107.52M1.48%-25.2M-35.03%-27.21M-25.45%-25.81M-34.56%-29.3M-16.89%-88.08M-32.54%-25.58M-5.41%-20.15M-8.28%-20.57M
Net non-operating interest income expense -194.89%-808K68.34%-1.2M53.38%-441K75.50%-246K74.40%-234K69.89%-274K-3.91%-3.77M-2.60%-946K-9.37%-1M-1.33%-914K
Non-operating interest income 27.66%1.07M1,992.24%4.58M629.80%1.45M9,814.29%1.39M22,750.00%914K27,733.33%835K2,090.00%219K6,500.00%198K600.00%14K33.33%4K
Non-operating interest expense 68.98%1.87M44.68%5.78M64.86%1.89M60.51%1.63M25.05%1.15M21.47%1.11M9.64%3.99M23.68%1.14M10.65%1.02M1.44%918K
Other net income (expense) -345.42%-13.65M483.90%7.63M354.89%6.54M5,809.98%25.18M-10,845.65%-29.66M646.58%5.56M79.51%-1.99M74.29%-2.57M-224.26%-441K3.37%276K
Gain on sale of security -352.90%-13.76M315.87%7.07M432.02%6.33M--25.16M-9,013.43%-29.86M2,990.34%5.44M564.75%1.7M460.61%1.19M----487.72%335K
Special income (charges) ------0--0--0--0----105.22%509K--0--0--0
-Less:Impairment of capital assets ------0------------------0------------
-Gain on sale of property,plant,equipment ------0--0--0--0------509K--0--0--0
Other non- operating income (expenses) -14.63%105K113.20%554K105.64%212K103.85%17K442.37%202K105.00%123K-1,085.21%-4.2M-3,747.57%-3.76M-495.95%-441K-128.10%-59K
Income before tax -115.47%-51.75M-7.73%-101.09M34.35%-19.1M89.45%-2.28M-162.62%-55.7M-9.45%-24.02M-5.82%-93.84M3.69%-29.09M-7.07%-21.6M-8.03%-21.21M
Income tax 375.00%19K178.57%78K135.71%33K300.00%26K275.00%15K-82.61%4K64.71%28K366.67%14K-750.00%-13K-33.33%4K
Net income -115.51%-51.77M-7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M-6.99%-21.59M-8.02%-21.21M
Net income continuous Operations -115.51%-51.77M-7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M-6.99%-21.59M-8.02%-21.21M
Minority interest income
Net income attributable to the parent company -115.51%-51.77M-7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M-6.99%-21.59M-8.02%-21.21M
Preferred stock dividends
Other preferred stock dividends 0000-81.74%2.55M0287K0
Net income attributable to common stockholders -115.51%-51.77M-4.93%-101.17M34.27%-19.13M89.46%-2.31M-162.64%-55.71M0.84%-24.02M6.07%-96.41M18.96%-29.1M-8.42%-21.87M-8.02%-21.21M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg